Hap Trading, LLC Mirati Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $3.1 Million - $7.42 Million	75,200 New	75,200 $139,000
Q2 2022 Aug 12, 2022	BUY	$39.16 - $88.71 $716,627 - $1.62 Million	18,300 New	18,300 $120,000
Q2 2021 Aug 11, 2021	SELL	$144.0 - $179.73 $3.96 Million - $4.94 Million	-27,500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $22.6 Million - $31.5 Million	-142,200 Reduced 83.79%	27,500 $101,000
Q4 2020 Feb 16, 2021	BUY	$162.05 - $240.27 $27.5 Million - $40.8 Million	169,700 New	169,700 $377,000
Q3 2020 Nov 13, 2020	SELL	$113.26 - $167.27 $5.67 Million - $8.38 Million	-50,100 Closed	0 $0
Q2 2020 Aug 10, 2020	SELL	$72.01 - $120.39 $2.92 Million - $4.89 Million	-40,600 Reduced 44.76%	50,100 $217,000
Q1 2020 May 08, 2020	BUY	$69.78 - $116.21 $5.25 Million - $8.75 Million	75,300 Added 488.96%	90,700 $174,000
Q4 2019 Feb 11, 2020	SELL	$70.76 - $128.86 $8.36 Million - $15.2 Million	-118,200 Reduced 88.47%	15,400 $160,000
Q3 2019 Nov 12, 2019	SELL	$77.91 - $109.6 $3.05 Million - $4.29 Million	-39,100 Reduced 22.64%	133,600 $397,000
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $7.87 Million - $13.9 Million	132,300 Added 327.48%	172,700 $852,000
Q1 2019 May 10, 2019	BUY	$43.65 - $78.95 $1.76 Million - $3.19 Million	40,400 New	40,400 $50,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.